SQ-109
SQ-109 Uses, Dosage, Side Effects, Food Interaction and all others data.
SQ-109 is an orally active, small molecule antibiotic for treatment of pulmonary TB. Currently in Phase I clinical trials, SQ-109 could replace one or more drugs in the current first-line TB drug regimen, simplify therapy, and shorten the TB treatment regimen.
Trade Name | SQ-109 |
Generic | SQ-109 |
Type | |
Formula | C22H38N2 |
Weight | Average: 330.5505 Monoisotopic: 330.303499226 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in bacterial infection, infectious and parasitic disease (unspecified), and tuberculosis.
How SQ-109 works
With a mechanism of action distinct from other antibiotics used in TB therapy, SQ109 inhibits cell wall synthesis and acts on multiple cellular pathways in a select group of microorganisms.
Innovators Monograph
You find simplified version here SQ-109